Videos

An MPCCC patient success story

Come with us as we go through the story of one of our MPCCC patients.

MPCCC Tech Talk: A/Prof Sefi Rosenbluh

High throughput methods to find new therapeutic targets

MPCCC – Monash BDI Cancer Discovery Seminar Series: Dr Oliver Klein

Immunotherapy using combined anti-PD-1/CTLA-4 checkpoint blockade in rare malignancies – Lessons learned from CA209-538 and Outlook towards MoST-CIRCUIT.

MPCCC Tech Talk: Associate Professor Jiangjing Song

Data Drive AI approaches for cancer diagnoses

The Role of Molecular Pathology In The Diagnosis of Brain Tumors

MPCCC - Monash BDI Cancer Discovery Seminar Series: The role of molecular pathology in the pathological diagnosis of primary brain tumours.

MPCCC Tech Talk: Claire Sun and Paul Daniel

Paediatric solid tumours are the leading cause of cancer related death amongst children. Identification of paediatric-specific targeted therapies necessitates the use of paediatric cancer models that faithfully recapitulate the patient’s disease.

MPCCC Tech Talk: Angela Von Czarnecki

SomaLogic, a part of Standard BioTools, is catalysing drug research and development and biomarker identification as a global leader in proteomics technology.

MPCCC Cancer Forum 2024

The Monash Partners Comprehensive Cancer Consortium (MPCCC) hosted its annual Cancer Forum on Friday, 23 February 2024 at the Huntingdale Golf Club

NGS based fusion testing in solid tumours by Dr Pranav Dorwal

Dr Pranav Dorwal is a RCPA certified molecular anatomical pathologist, who works in the department of Pathology at Monash Health. Dr Dorwal has strong interest in medical education and research and has more than 60 publications to his credit.